Weekly imatinib dosage for chronic eosinophilic leukaemia expressing FIP1L1‐PDGFRA fusion transcript: extended follow‐up

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of haematology 2009-04, Vol.145 (1), p.132-134
Hauptverfasser:	Helbig, Grzegorz, Moskwa, Andrzej, Swiderska, Alina, Urbanowicz, Alina, Całbecka, Małgorzata, Gajkowska, Justyna, Zdziarska, Barbara, Brzeźniakiewicz, Katarzyna, Pogrzeba, Joanna, Krzemień, Sławomira
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Antineoplastic Agents - therapeutic use Benzamides chronic eosinophilic leukaemia Drug Administration Schedule Female FIP1L1‐PDGFRA Follow-Up Studies Humans Hypereosinophilic Syndrome - drug therapy Hypereosinophilic Syndrome - genetics imatinib Imatinib Mesylate Male Middle Aged mRNA Cleavage and Polyadenylation Factors Oncogene Proteins, Fusion Piperazines - therapeutic use Pyrimidines - therapeutic use Receptor, Platelet-Derived Growth Factor alpha Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!